Detalhe da pesquisa
1.
Peripheral blood CD34+ percentage at hematological recovery after chemotherapy is a good early predictor of harvest: a single-center experience.
Biol Blood Marrow Transplant
; 20(5): 717-23, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24525280
2.
Effects of erythropoiesis-stimulating agents on overall survival of International Prognostic Scoring System Low/Intermediate-1 risk, transfusion-independent myelodysplastic syndrome patients: a cohort study.
Haematologica
; 104(1): e4-e8, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30076178
3.
Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes.
Eur J Haematol
; 87(5): 409-18, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21711395
4.
Diagnosis of maternal Hodgkin lymphoma following abnormal findings at noninvasive prenatal screening test (NIPT): Report of two cases.
Clin Case Rep
; 9(3): 1066-1071, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33768784
5.
Immunoglobulin M (IgM) multiple myeloma versus Waldenström macroglobulinemia: diagnostic challenges and therapeutic options: two case reports.
J Med Case Rep
; 14(1): 75, 2020 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32564775
6.
Erythroid response during iron chelation therapy in a cohort of patients affected by hematologic malignancies and aplastic anemia with transfusion requirement and iron overload: a FISM Italian multicenter retrospective study.
Leuk Lymphoma
; 58(11): 2752-2754, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28482720